I 
117TH CONGRESS 
1ST SESSION H. R. 5467 
To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial 
intelligence and machine learning technologies can qualify as a practi-
tioner eligible to prescribe drugs if authorized by the State involved 
and approved, cleared, or authorized by the Food and Drug Administra-
tion, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 30, 2021 
Mr. SCHWEIKERT introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
clarify that artificial intelligence and machine learning 
technologies can qualify as a practitioner eligible to pre-
scribe drugs if authorized by the State involved and 
approved, cleared, or authorized by the Food and Drug 
Administration, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Healthy Technology 
4
Act of 2021’’. 
5
VerDate Sep 11 2014 
02:46 Oct 06, 2021
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5467.IH
H5467
kjohnson on DSK79L0C42PROD with BILLS
2 
•HR 5467 IH
SEC. 2. PRESCRIPTION OF DRUGS BY ARTIFICIAL INTEL-
1
LIGENCE OR MACHINE LEARNING TECH-
2
NOLOGIES. 
3
Section 503(b) of Federal Food, Drug, and Cosmetic 
4
Act (21 U.S.C. 353(b)) is amended by adding at the end 
5
the following: 
6
‘‘(6) In this subsection, the term ‘practitioner li-
7
censed by law to administer such drug’ includes artificial 
8
intelligence and machine learning technology that are— 
9
‘‘(A) authorized pursuant to a statute of the 
10
State involved to prescribe the drug involved; and 
11
‘‘(B) approved, cleared, or authorized under 
12
section 510(k), 513, 515, or 564.’’. 
13
Æ 
VerDate Sep 11 2014 
02:46 Oct 06, 2021
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H5467.IH
H5467
kjohnson on DSK79L0C42PROD with BILLS
